Sigyn Therapeutics Stock Market Value
| SIGY Stock | USD 1.71 0.19 10.00% |
| Symbol | Sigyn |
Sigyn Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Sigyn Therapeutics' otc stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Sigyn Therapeutics.
| 06/28/2025 |
| 12/25/2025 |
If you would invest 0.00 in Sigyn Therapeutics on June 28, 2025 and sell it all today you would earn a total of 0.00 from holding Sigyn Therapeutics or generate 0.0% return on investment in Sigyn Therapeutics over 180 days. Sigyn Therapeutics is related to or competes with Zelira Therapeutics. Sigyn Therapeutics, Inc. operates as a development-stage therapeutic technology company More
Sigyn Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Sigyn Therapeutics' otc stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Sigyn Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.05) | |||
| Maximum Drawdown | 87.42 | |||
| Value At Risk | (26.40) | |||
| Potential Upside | 5.26 |
Sigyn Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Sigyn Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Sigyn Therapeutics' standard deviation. In reality, there are many statistical measures that can use Sigyn Therapeutics historical prices to predict the future Sigyn Therapeutics' volatility.| Risk Adjusted Performance | (0.02) | |||
| Jensen Alpha | (0.64) | |||
| Total Risk Alpha | (1.59) | |||
| Treynor Ratio | (0.18) |
Sigyn Therapeutics Backtested Returns
Sigyn Therapeutics owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0497, which indicates the firm had a -0.0497 % return per unit of risk over the last 3 months. Sigyn Therapeutics exposes twenty-one different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Sigyn Therapeutics' Variance of 129.44, risk adjusted performance of (0.02), and Coefficient Of Variation of (2,544) to confirm the risk estimate we provide. The entity has a beta of 2.59, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Sigyn Therapeutics will likely underperform. At this point, Sigyn Therapeutics has a negative expected return of -0.57%. Please make sure to validate Sigyn Therapeutics' standard deviation, potential upside, as well as the relationship between the Potential Upside and day typical price , to decide if Sigyn Therapeutics performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.31 |
Poor reverse predictability
Sigyn Therapeutics has poor reverse predictability. Overlapping area represents the amount of predictability between Sigyn Therapeutics time series from 28th of June 2025 to 26th of September 2025 and 26th of September 2025 to 25th of December 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Sigyn Therapeutics price movement. The serial correlation of -0.31 indicates that nearly 31.0% of current Sigyn Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.31 | |
| Spearman Rank Test | -0.51 | |
| Residual Average | 0.0 | |
| Price Variance | 0.3 |
Sigyn Therapeutics lagged returns against current returns
Autocorrelation, which is Sigyn Therapeutics otc stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Sigyn Therapeutics' otc stock expected returns. We can calculate the autocorrelation of Sigyn Therapeutics returns to help us make a trade decision. For example, suppose you find that Sigyn Therapeutics has exhibited high autocorrelation historically, and you observe that the otc stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Sigyn Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Sigyn Therapeutics otc stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Sigyn Therapeutics otc stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Sigyn Therapeutics otc stock over time.
Current vs Lagged Prices |
| Timeline |
Sigyn Therapeutics Lagged Returns
When evaluating Sigyn Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Sigyn Therapeutics otc stock have on its future price. Sigyn Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Sigyn Therapeutics autocorrelation shows the relationship between Sigyn Therapeutics otc stock current value and its past values and can show if there is a momentum factor associated with investing in Sigyn Therapeutics.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Sigyn OTC Stock Analysis
When running Sigyn Therapeutics' price analysis, check to measure Sigyn Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sigyn Therapeutics is operating at the current time. Most of Sigyn Therapeutics' value examination focuses on studying past and present price action to predict the probability of Sigyn Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sigyn Therapeutics' price. Additionally, you may evaluate how the addition of Sigyn Therapeutics to your portfolios can decrease your overall portfolio volatility.